oncology
Thermo Fisher and Pfizer collaborate on NGS-based cancer tests
May 10, 2023Medical Communications Cancer, NGS, Oncology, Pfizer, Thermo Fisher Scientifitic, oncology
Scientific equipment provider Thermo Fisher and US pharmaceutical firm Pfizer have announced a collaboration to advance next-generation sequencing (NGS)-based cancer …
Nanobiotix enters final contract negotiations with major pharma company
May 5, 2023Medical Communications FDA, Oncology, nanobiotix, oncology
French late-stage clinical biotechnology company Nanobiotix has announced that it has entered into final contract negotiations with a major pharmaceutical …
EMA validates HUTCHMED MAA for neuroendocrine tumour drug
July 16, 2021Medical Communications EU, oncology
China-based biotech HUTCHMED has announced that the EMA has validated and accepted the Marketing Authorisation Application (MAA) for surufatinib, for …
Novel cancer therapy kick starts clinical trials
July 6, 2021Manufacturing and Production oncology
The first patient has been dosed in Phase 1/2 trials investigating a new form of cancer therapy, gamma delta TCR …
Birmingham University & Nonacus to develop urine test for bladder cancer
July 1, 2021bladder cancer, cfdna, oncology
The University of Birmingham has partnered with Nonacus to develop a non-invasive test for bladder cancer. The test, which is …
Personalised medicine in oncology: Where are we now?
June 30, 2021Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AI, Cancer, oncology, presonalised medicine, surgery
The past decade has seen exponential growth in the field of oncology, with precision medicine at the forefront, driving positive …
Medical cannabis formulation kills breast cancer cells in trial
June 28, 2021Sales and Marketing breast cancer, medical cannabis, oncology
UK-based pharma company, Apollon Formularies, have announced that their medical cannabis formulations were successful in killing triple-negative breast cancer (TNBC) …
New test proven to detect over 50 types of cancer
June 25, 2021Medical Communications Cancer. test, US, oncology
Final results from a study into a new blood test that can detect more than 50 types of cancer have …
Breakthrough announced in circulating tumour cell research
June 18, 2021Medical Communications Cancer, Circulating tumour cells, Precision Medicine, oncology
Liquid biopsy company, Angle, has announced results from their study in non-small cell lung cancer (NSCLC) which demonstrates the benefit …
New class of cancer-killing drugs identified
June 18, 2021Medical Communications Cancer, oncology
Scientists have announced the identification of a new class of cancer drugs, known as POLQ inhibitors, that specifically kill cancer …
COVID chaos: Survey reveals global oncology trial disruptions
June 10, 2021data, oncology
The pandemic has had a widespread impact across the healthcare industry and the world, however, a recent global survey from …
Astronomy & cancer: Researchers join forces to study CUP
June 7, 2021Sales and Marketing oncology
Astronomers from Durham University have joined forces with cancer researchers to advance the diagnosis and treatment of cancer of unknown …
BMS announce new positive data from oesophageal cancer study
June 4, 2021Medical Communications Cancer, oncology
Bristol Myers Squibb (BMS) has announced results from the Phase III CheckMate -648 trial in which nivolumab plus chemotherapy and …
AstraZeneca’s lung cancer drug gains EU approval
May 28, 2021Medical Communications AstraZeneca, EU, lung cancer, oncology
AstraZeneca’s Tagrisso (osimertinib) has been approved in the EU for the adjuvant treatment of adult patients with early-stage (IB, II …
AstraZeneca secures MHRA licensing and NHS early access for lung cancer drug
May 7, 2021Medical Communications Astrazenaca, oncology
AstraZeneca have announced that the MHRA has granted a license extension for Tagrisso (osimertinib) in the UK, for use as …
Latest content
FibroFind appoints Lee Borthwick as CEO
